GEMIN6 Overexpression Correlates with the Low Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma

Figure 1

GEMIN6 expression in LUAD and other types of human cancers from TCGA data. (a) GEMIN6 expression in different tumor types; (b) the expression of GEMIN6 in LUAD and its paired adjacent tissues; (c) the expression of GEMIN6 in LUAD and normal tissues; (d) the association of GEMIN6 expression and T stages in LUAD; (e) the association of GEMIN6 expression and pathologic stages in LUAD; (f) the association of GEMIN6 expression and N stages in LUAD; (g) relative expression of GEMIN6 in human bronchial epithelial cells (BEAS-2B) and LUAD cell lines (A549, H1299, SK-MES-1, PC-9, and NCI-H23); (h) receiver operating characteristic analysis (ROC) of GEMIN6 in LUAD.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)